Here, we provide insight into gene regulation at the C9orf72 locus that will directly impact the development of therapeutics for C9orf72-related diseases including frontotemporal dementia (FTD) and ALS (amyotrophic lateral sclerosis). This evidence concerns the gene C9orf72 and frontotemporal dementia.